OQORY
Dead / Abandoned — Abandoned — no statement of use filed (as of 29 Sept 2025)
What this means for you
This application is over — abandoned 29 Sept 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97285043
- Mark type
- Stylized text
- Filed
- 25 Feb 2022
- Published for opposition
- 03 Jan 2023
- Abandoned
- 29 Sept 2025
- Attorney of record
- Lindsay J. Hulley
Goods and services
- Class 005 — Pharmaceuticals: Mesenchymal stem cells for medical purposes for use in the treatment and prevention of Covid-19 and Coronaviruses; Pharmaceutical preparations for human use, namely, Mesenchymal stem cells for medical or clinical use for the treatment and prevention of Covid-19 and Coronaviruses; Pharmaceutical preparations featuring Mesenchymal stem cells for the treatment and prevention of infectious diseases, namely, COVID-19 and Coronaviruses
Owner
- VIVASOR, INC., SAN DIEGO, CA, US
- Sorrento Therapeutics, Inc., San Diego, CA, US
- Sorrento Therapeutics, Inc., San Diego, CA, US
Prosecution history
- 29 Sept 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 29 Sept 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 27 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2025 — SOU EXTENSION 4 GRANTED
- 26 Feb 2025 — SOU EXTENSION 4 FILED
- 26 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 22 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Aug 2024 — SOU EXTENSION 3 GRANTED
- 23 Aug 2024 — SOU EXTENSION 3 FILED
- 22 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 24 Apr 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 01 Feb 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Jan 2024 — SOU EXTENSION 2 GRANTED
- 30 Jan 2024 — SOU EXTENSION 2 FILED
- 30 Jan 2024 — SOU TEAS EXTENSION RECEIVED